IPO - ORBIMED ADVISORS LLC

Form Type: SCHEDULE 13D

Filing Date: 2025-02-13

Corporate Action: Ipo

Type: New

Accession Number: 000094787125000138

Filing Summary: OrbiMed Advisors LLC, along with OrbiMed Capital GP VIII LLC, reported significant investments in Sionna Therapeutics, Inc. They acquired 3,704,959 Shares which constitutes approximately 8.4% of the company's outstanding Shares. The investments were made as part of their strategy for potential growth and market presence and not with the intent to gain control over the company. The Shares represent a result of prior acquisitions of preferred stock which converted into common Shares during the company's IPO process. They participated in the IPO by purchasing 550,000 Shares at $18.00 each. The investment decisions are based on various factors including financial performance and market conditions. The document specifies that no plans for further securities acquisition, merger, or significant changes in company structure or management are anticipated at this time. Additionally, the Reporting Persons maintain a joint filing agreement and describe various rights related to registration and securities management post-IPO, including demand and piggyback registration rights that will be effective after the IPO completion.

Document Link: View Document